
Thomas Brown
Examiner (ID: 11072)
| Most Active Art Unit | 2601 |
| Art Unit(s) | 2786, 2899, 2742, 2787, 2306, 2601, 2604, 2305, 2857 |
| Total Applications | 1242 |
| Issued Applications | 1062 |
| Pending Applications | 29 |
| Abandoned Applications | 151 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 8363261
[patent_doc_number] => 08252325
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-08-28
[patent_title] => 'Liposome-encapsulated glutathione for oral administration'
[patent_app_type] => utility
[patent_app_number] => 13/396841
[patent_app_country] => US
[patent_app_date] => 2012-02-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7348
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 39
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13396841
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/396841 | Liposome-encapsulated glutathione for oral administration | Feb 14, 2012 | Issued |
Array
(
[id] => 8323563
[patent_doc_number] => 20120195972
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-08-02
[patent_title] => 'OPHTHALMIC FORMULATIONS AND USES THEREOF'
[patent_app_type] => utility
[patent_app_number] => 13/369452
[patent_app_country] => US
[patent_app_date] => 2012-02-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6824
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13369452
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/369452 | Ophthalmic formulations and uses thereof | Feb 8, 2012 | Issued |
Array
(
[id] => 11191462
[patent_doc_number] => 09422261
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-08-23
[patent_title] => 'Heterocyclic resorcinol derivatives, preparation of same and cosmetic uses thereof'
[patent_app_type] => utility
[patent_app_number] => 13/983742
[patent_app_country] => US
[patent_app_date] => 2012-02-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9248
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13983742
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/983742 | Heterocyclic resorcinol derivatives, preparation of same and cosmetic uses thereof | Feb 6, 2012 | Issued |
Array
(
[id] => 8209278
[patent_doc_number] => 20120128848
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-05-24
[patent_title] => 'THIN FILM WITH NON-SELF-AGGREGATING UNIFORM HETEROGENEITY AND DRUG DELIVERY SYSTEMS MADE THEREFROM'
[patent_app_type] => utility
[patent_app_number] => 13/342614
[patent_app_country] => US
[patent_app_date] => 2012-02-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 34
[patent_figures_cnt] => 34
[patent_no_of_words] => 20859
[patent_no_of_claims] => 196
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0128/20120128848.pdf
[firstpage_image] =>[orig_patent_app_number] => 13342614
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/342614 | THIN FILM WITH NON-SELF-AGGREGATING UNIFORM HETEROGENEITY AND DRUG DELIVERY SYSTEMS MADE THEREFROM | Feb 1, 2012 | Abandoned |
Array
(
[id] => 8606030
[patent_doc_number] => 20130011343
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-01-10
[patent_title] => 'CHEWING GUM HAVING SUSTAINED RELEASE OF NICOTINE'
[patent_app_type] => utility
[patent_app_number] => 13/360102
[patent_app_country] => US
[patent_app_date] => 2012-01-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8126
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13360102
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/360102 | Chewing gum having sustained release of nicotine | Jan 26, 2012 | Issued |
Array
(
[id] => 8875394
[patent_doc_number] => 08470352
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-06-25
[patent_title] => 'Magnesium compositions and uses thereof for metabolic disorders'
[patent_app_type] => utility
[patent_app_number] => 13/357216
[patent_app_country] => US
[patent_app_date] => 2012-01-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 29
[patent_figures_cnt] => 29
[patent_no_of_words] => 37218
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 38
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13357216
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/357216 | Magnesium compositions and uses thereof for metabolic disorders | Jan 23, 2012 | Issued |
Array
(
[id] => 9136325
[patent_doc_number] => 20130297040
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-11-07
[patent_title] => 'IMPLANT HAVING A CORE AND A TUBE ENCASING THE CORE'
[patent_app_type] => utility
[patent_app_number] => 13/979642
[patent_app_country] => US
[patent_app_date] => 2012-01-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 18
[patent_no_of_words] => 16823
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13979642
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/979642 | IMPLANT HAVING A CORE AND A TUBE ENCASING THE CORE | Jan 15, 2012 | Abandoned |
Array
(
[id] => 9108845
[patent_doc_number] => 20130281977
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-10-24
[patent_title] => 'DEVICE FOR CONTROLLED RELEASE OF A BIOACTIVE AGENT'
[patent_app_type] => utility
[patent_app_number] => 13/977332
[patent_app_country] => US
[patent_app_date] => 2011-12-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 17
[patent_no_of_words] => 12472
[patent_no_of_claims] => 36
[patent_no_of_ind_claims] => 16
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13977332
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/977332 | Device for controlled release of a bioactive agent | Dec 28, 2011 | Issued |
Array
(
[id] => 9222408
[patent_doc_number] => 20140017183
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-01-16
[patent_title] => 'PROCESS FOR THE MANUFACTURE OF DIBENZOYLMETHANE DERIVATIVES'
[patent_app_type] => utility
[patent_app_number] => 13/996042
[patent_app_country] => US
[patent_app_date] => 2011-12-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3972
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13996042
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/996042 | Process for the manufacture of dibenzoylmethane derivatives | Dec 18, 2011 | Issued |
Array
(
[id] => 8289395
[patent_doc_number] => 20120177719
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-07-12
[patent_title] => 'MEDICAL DEVICE INTENDED TO COME INTO CONTACT WITH A PATIENT\'S TISSUE AND RELATED MANUFACTURING METHOD'
[patent_app_type] => utility
[patent_app_number] => 13/316022
[patent_app_country] => US
[patent_app_date] => 2011-12-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 5386
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13316022
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/316022 | Medical device intended to come into contact with a patient's tissue and related manufacturing method | Dec 8, 2011 | Issued |
Array
(
[id] => 8510427
[patent_doc_number] => 20120309835
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-12-06
[patent_title] => 'METHODS, ASSAYS AND COMPOSITIONS FOR TREATING RETINOL-RELATED DISEASES'
[patent_app_type] => utility
[patent_app_number] => 13/314035
[patent_app_country] => US
[patent_app_date] => 2011-12-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 20
[patent_no_of_words] => 35724
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13314035
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/314035 | METHODS, ASSAYS AND COMPOSITIONS FOR TREATING RETINOL-RELATED DISEASES | Dec 6, 2011 | Abandoned |
Array
(
[id] => 8612746
[patent_doc_number] => 20130018058
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-01-17
[patent_title] => 'PHARMACEUTICALLY ACCEPTABLE SALTS OF QUINOLINONE COMPOUNDS HAVING IMPROVED PHARMACEUTICAL PROPERTIES'
[patent_app_type] => utility
[patent_app_number] => 13/309879
[patent_app_country] => US
[patent_app_date] => 2011-12-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 18
[patent_no_of_words] => 69154
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13309879
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/309879 | PHARMACEUTICALLY ACCEPTABLE SALTS OF QUINOLINONE COMPOUNDS HAVING IMPROVED PHARMACEUTICAL PROPERTIES | Dec 1, 2011 | Abandoned |
Array
(
[id] => 9080996
[patent_doc_number] => 20130266526
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-10-10
[patent_title] => 'DIHYDROXYFUMARIC ACID DERIVATIVES AND THE USE THEREOF FOR SKIN LIGHTENING'
[patent_app_type] => utility
[patent_app_number] => 13/988112
[patent_app_country] => US
[patent_app_date] => 2011-10-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15649
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13988112
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/988112 | DIHYDROXYFUMARIC ACID DERIVATIVES AND THE USE THEREOF FOR SKIN LIGHTENING | Oct 20, 2011 | Abandoned |
Array
(
[id] => 8406567
[patent_doc_number] => 20120238636
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-09-20
[patent_title] => 'RASAGILINE ORALLY DISINTEGRATING COMPOSITIONS'
[patent_app_type] => utility
[patent_app_number] => 13/279100
[patent_app_country] => US
[patent_app_date] => 2011-10-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8758
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 14
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13279100
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/279100 | RASAGILINE ORALLY DISINTEGRATING COMPOSITIONS | Oct 20, 2011 | Abandoned |
Array
(
[id] => 9026134
[patent_doc_number] => 08535714
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-09-17
[patent_title] => 'Small volume oral transmucosal dosage forms containing sufentanil for treatment of pain'
[patent_app_type] => utility
[patent_app_number] => 13/276165
[patent_app_country] => US
[patent_app_date] => 2011-10-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 23
[patent_figures_cnt] => 25
[patent_no_of_words] => 34205
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 177
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13276165
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/276165 | Small volume oral transmucosal dosage forms containing sufentanil for treatment of pain | Oct 17, 2011 | Issued |
Array
(
[id] => 7766382
[patent_doc_number] => 20120034311
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-02-09
[patent_title] => 'Topical formulations for the prevention of sexually transmitted disease and methods of producing the same'
[patent_app_type] => utility
[patent_app_number] => 13/274813
[patent_app_country] => US
[patent_app_date] => 2011-10-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3541
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0034/20120034311.pdf
[firstpage_image] =>[orig_patent_app_number] => 13274813
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/274813 | Topical formulations for the prevention of sexually transmitted disease and methods of producing the same | Oct 16, 2011 | Issued |
Array
(
[id] => 9568563
[patent_doc_number] => 20140186276
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-07-03
[patent_title] => 'MULTI-TEXTURED ANIMAL TREATS'
[patent_app_type] => utility
[patent_app_number] => 14/238314
[patent_app_country] => US
[patent_app_date] => 2011-09-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 7250
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14238314
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/238314 | Multi-textured animal treats | Sep 28, 2011 | Issued |
Array
(
[id] => 9268740
[patent_doc_number] => 20140023656
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-01-23
[patent_title] => 'PHARMACEUTICAL COMPOSITION FOR TREATMENT AND PREVENTION OF TH3 MARCH-RELATED DISEASES'
[patent_app_type] => utility
[patent_app_number] => 13/824672
[patent_app_country] => US
[patent_app_date] => 2011-09-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 22603
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13824672
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/824672 | PHARMACEUTICAL COMPOSITION FOR TREATMENT AND PREVENTION OF TH3 MARCH-RELATED DISEASES | Sep 25, 2011 | Abandoned |
Array
(
[id] => 8081097
[patent_doc_number] => 08147869
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-04-03
[patent_title] => 'Liposome-encapsulated glutathione for oral administration'
[patent_app_type] => utility
[patent_app_number] => 13/222254
[patent_app_country] => US
[patent_app_date] => 2011-08-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7136
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 39
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/147/08147869.pdf
[firstpage_image] =>[orig_patent_app_number] => 13222254
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/222254 | Liposome-encapsulated glutathione for oral administration | Aug 30, 2011 | Issued |
Array
(
[id] => 11303690
[patent_doc_number] => 09511071
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-12-06
[patent_title] => 'Compounds and compositions for ossification and methods related thereto'
[patent_app_type] => utility
[patent_app_number] => 13/816312
[patent_app_country] => US
[patent_app_date] => 2011-08-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 26
[patent_figures_cnt] => 26
[patent_no_of_words] => 16796
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 39
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13816312
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/816312 | Compounds and compositions for ossification and methods related thereto | Aug 17, 2011 | Issued |